Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Accumulated Expenses (2014 - 2018)

Viking Therapeutics' (VKTX) quarterly Accumulated Expenses came in at $34000.0 in Q1 2018, up 54.55% quarter-over-quarter from $22000.0 in Q4 2017.

Analysis

Viking Therapeutics (VKTX) Accumulated Expenses (2014 - 2018) Analysis & Trends

Viking Therapeutics has disclosed Accumulated Expenses across 5 years of filings, most recently posting $34000.0 for Q1 2018.

  • In Q1 2018, Accumulated Expenses changed N/A year-over-year to $34000.0; the TTM figure through Mar 2018 stood at $34000.0 (changed N/A YoY), while the FY2017 annual figure was $22000.0, down 36.95% from the prior year.
  • Accumulated Expenses came in at $34000.0 for Q1 2018 at Viking Therapeutics, up from $22000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $183611.0 in Q4 2015 to a low of $9982.0 in Q3 2017.
  • Average Accumulated Expenses over 5 years is $70009.8, with a median of $47113.5 recorded in 2016.
  • Year-over-year, Accumulated Expenses plunged 91.37% in 2016 and surged 467.51% in 2017.
  • Over 5 years, Accumulated Expenses stood at $77222.0 in 2014, then soared by 137.77% to $183611.0 in 2015, then sank by 81.0% to $34894.0 in 2016, then tumbled by 36.95% to $22000.0 in 2017, then soared by 54.55% to $34000.0 in 2018.
  • Per Business Quant data, the three most recent Accumulated Expenses figures were $34000.0 in Q1 2018, $22000.0 in Q4 2017, and $9982.0 in Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 34,000.00
Dec 31, 2017 22,000.00
Sep 30, 2017 9,982.00
Jun 30, 2017 59,333.00
Dec 31, 2016 34,894.00
Sep 30, 2016 22,674.00
Jun 30, 2016 10,455.00
Dec 31, 2015 183,611.00
Sep 30, 2015 152,361.00
Jun 30, 2015 121,111.00
Mar 31, 2015 112,475.00
Dec 31, 2014 77,222.00
API Access

Viking Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY